Revista médica de Chile
-
Revista médica de Chile · Sep 2000
Case Reports[Efficacy of gemcitabine in the gallbladder cancer. Initial experience in 4 cases].
Surgery continues to be the only curative therapy for gallbladder cancer, but useful in very few patients. Mean survival of patients with gallbladder cancer, that are out of the reach of surgery, is 3 months. The few clinical trials of chemotherapy for this disease, report very low success rates. ⋯ In all patients, symptoms were alleviated, functional status and quality of life improved. Toxicity was mild and did not require reduction in doses or delay in therapy. Therefore, this medication deserves further investigation for the treatment of gallbladder cancer.